Regeneron Pharmaceuticals Inc (REGN) — Cash Flow Quality Index
Regeneron Pharmaceuticals Inc (REGN) has a Cash Flow Quality Index of 1.48x as of March 2026. Operating cash flow of $1.08 Billion exceeds net income of $727.20 Million, indicating high earnings quality where cash backs reported profits. Explore REGN strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Regeneron Pharmaceuticals Inc Cash Flow Quality Index (2004–2025)
Historical Cash Flow Quality Index for Regeneron Pharmaceuticals Inc across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Regeneron Pharmaceuticals Inc (REGN) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Regeneron Pharmaceuticals Inc (2004–2025)
Year-by-year earnings quality comparison for Regeneron Pharmaceuticals Inc. For live market cap and the full company financial profile, see REGN company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.11x | $4.98 Billion | $4.50 Billion | ▲ +10.3% |
| 2024 | 1.00x | $4.42 Billion | $4.41 Billion | ▼ -13.8% |
| 2023 | 1.16x | $4.59 Billion | $3.95 Billion | ▲ +0.5% |
| 2022 | 1.16x | $5.01 Billion | $4.34 Billion | ▲ +31.8% |
| 2021 | 0.88x | $7.08 Billion | $8.08 Billion | ▲ +17.7% |
| 2020 | 0.75x | $2.62 Billion | $3.51 Billion | ▼ -35.1% |
| 2019 | 1.15x | $2.43 Billion | $2.12 Billion | ▲ +27.9% |
| 2018 | 0.90x | $2.20 Billion | $2.44 Billion | ▼ -17.7% |
| 2017 | 1.09x | $1.31 Billion | $1.20 Billion | ▼ -34.3% |
| 2016 | 1.66x | $1.49 Billion | $895.52 Million | ▼ -20.7% |
| 2015 | 2.09x | $1.33 Billion | $636.06 Million | ▼ -3.2% |
| 2014 | 2.16x | $752.43 Million | $348.07 Million | ▲ +55.9% |
| 2013 | 1.39x | $588.60 Million | $424.36 Million | ▲ +1494.7% |
| 2012 | -0.10x | $-74.61 Million | $750.27 Million | ▲ +75.5% |
| 2004 | -0.41x | $-16.91 Million | $41.70 Million | — |